Ascendis Pharma A/S Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 10.28 M | $2.19 B | 0.00% | 16.96% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 5.19 M | $1.11 B | -1.41% | 8.50% |
| AVORO CAPITAL ADVISORS LLC | 02/17/2026 | 5.11 M | $1.09 B | 0.02% | 8.43% |
| FMR LLC | 02/17/2026 | 4.15 M | $885.65 M | -7.12% | 6.85% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.06 M | $866.10 M | -6.05% | 6.70% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/17/2026 | 3.23 M | $687.89 M | -13.30% | 5.32% |
| CAPITAL INTERNATIONAL INVESTORS | 02/11/2026 | 3.06 M | $653.36 M | 0.11% | 5.02% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 1.91 M | $407.31 M | 20.13% | 3.13% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 01/22/2026 | 1.89 M | $402.25 M | 0.19% | 3.09% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 1.76 M | $375.88 M | -2.01% | 2.91% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/19/2026 | 1.67 M | $355.61 M | -37.46% | 2.75% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 1.57 M | $334.84 M | -9.04% | 2.59% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.44 M | $307.74 M | 164.99% | 2.38% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 1.08 M | $230.60 M | -0.65% | 1.78% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 1.03 M | $218.87 M | 29.32% | 1.68% |
| BLACKROCK, INC. | 02/12/2026 | 628.20 K | $133.96 M | 39.14% | 1.04% |
| MORGAN STANLEY | 02/13/2026 | 617.97 K | $131.78 M | 51.92% | 1.02% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 596.70 K | $127.24 M | -8.62% | 0.98% |
| INVESCO LTD. | 02/19/2026 | 586.09 K | $124.98 M | -36.15% | 0.97% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 550.48 K | $117.38 M | -2.21% | 0.91% |
| CITADEL ADVISORS LLC | 02/17/2026 | 519.52 K | $110.78 M | 1,779.58% | 0.86% |
| JPMORGAN CHASE & CO | 02/11/2026 | 507.24 K | $108.16 M | 73.48% | 0.83% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 496.84 K | $105.95 B | 100.00% | 0.82% |
| FIL LTD | 02/17/2026 | 478.64 K | $102.07 M | 4.20% | 0.79% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 470.95 K | $100.43 M | 100.00% | 0.78% |
| SPYGLASS CAPITAL MANAGEMENT LLC | 02/17/2026 | 415.55 K | $88.61 M | 6.92% | 0.69% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 370.47 K | $79.00 M | -56.82% | 0.61% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 352.11 K | $75.08 M | 106.27% | 0.58% |
| UBS GROUP AG | 01/29/2026 | 308.19 K | $65.72 M | 57.88% | 0.51% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 307.09 K | $65.48 M | 28.74% | 0.51% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 296.82 K | $63.29 M | 326.71% | 0.49% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 288.59 K | $61.54 M | -23.23% | 0.48% |
| SEI INVESTMENTS CO | 02/13/2026 | 281.47 K | $60.02 M | 37.09% | 0.46% |
| TRI LOCUM PARTNERS LP | 02/17/2026 | 265.02 K | $56.51 M | 51.59% | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 262.33 K | $55.94 M | 50.24% | 0.43% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 247.89 K | $52.86 M | 34.81% | 0.41% |
| SIREN, L.L.C. | 02/13/2026 | 235.86 K | $50.30 M | 0.00% | 0.39% |
| TD ASSET MANAGEMENT INC | 02/10/2026 | 234.01 K | $49.90 M | -21.03% | 0.38% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 230.00 K | $49.05 M | 117.80% | 0.38% |
| ABRDN PLC | 01/16/2026 | 221.68 K | $47.27 M | 348.50% | 0.36% |
| JAIN GLOBAL LLC | 02/17/2026 | 216.53 K | $46.17 M | 502.10% | 0.36% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 216.17 K | $46.10 M | -7.77% | 0.36% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 203.50 K | $43.39 M | -5.13% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 196.80 K | $41.97 M | 68.35% | 0.32% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 193.46 K | $41.25 M | -33.33% | 0.32% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 194.61 K | $41.50 M | -7.02% | 0.32% |
| Q GLOBAL ADVISORS, LLC | 02/17/2026 | 190.00 K | $40.52 M | 11.76% | 0.31% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/15/2026 | 187.64 K | $40.02 M | -2.10% | 0.31% |
| CANDRIAM S.C.A. | 02/13/2026 | 186.94 K | $39.86 M | 4.46% | 0.31% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 182.23 K | $38.86 M | 7.26% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ascendis Pharma A/S institutional Ownership - FAQ's
During the previous two years, 381 institutional investors and hedge funds held shares of Ascendis Pharma A/S. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.28 M
WESTFIELD CAPITAL MANAGEMENT CO LP: 5.19 M
Avoro Capital Advisors LLC: 5.11 M
FMR LLC: 4.15 M
JANUS HENDERSON GROUP PLC: 4.06 M
Artisan Partners Limited Partnership: 3.23 M
106.04% of Ascendis Pharma A/S stock is owned by institutional investors.
Institutional investors have bought a total of 67.86 M shares in the last 24 months. This purchase volume represents approximately $15.25 B in transactions.